Answers are grounded in this paper and cite their sources.
Neoadjuvant therapy is a standard treatment for locally advanced gastric cancer, yet a substantial fraction of patients develop resistance that is not adequately captured by conventional staging systems or bulk immune metrics. In particular, the spatial immune mechanisms linking macrophage states to therapeutic response remain insufficiently defined. An integrated multi-omics analysis was performed using 27 gastric cancer scRNA-seq samples spanning normal adjacent tissue, pre-treatment tumors, neoadjuvant-sensitive tumors, and neoadjuvant-resistant tumors, together with spatial transcriptomics and multiplex immunofluorescence. Macrophage heterogeneity, spatial organization, and macrophage–CD8⁺ T cell interactions were characterized across treatment states. The functional relevance of Cd74 was further evaluated in an MFC allograft model using AAV-mediated Cd74 depletion combined with XELOX treatment, followed by immunofluorescence and Luminex-based cytokine profiling. Across 120,718 cells, an APOE⁺CD74⁺ macrophage state was identified as selectively enriched in resistant tumors. Spatial analyses showed that these macrophages preferentially accumulated at tumor-stroma interfaces, forming boundary-associated niches characterized by altered CD8⁺ T cell localization, increased exhaustion, and reduced cytotoxicity. Ligand-receptor prioritization highlighted the CCL3–CCR5 and HLA-DQA2–LAG3 axes as candidate mediators of these interactions. In vivo, Cd74 depletion suppressed tumor growth and enhanced the antitumor efficacy of XELOX. This effect was accompanied by reduced proportions of Cd74⁺Cd68⁺ cells and Lag3⁺Cd8⁺ cells within tumor tissues. Luminex analysis further demonstrated that Cd74 depletion combined with XELOX remodeled the intratumoral cytokine milieu, supporting broader immune-context reprogramming associated with disruption of the Cd74 axis. These findings identify a boundary-associated APOE⁺CD74⁺ macrophage–CD8⁺ T cell niche linked to neoadjuvant resistance in gastric cancer and provide in vivo evidence that the Cd74 axis contributes to chemotherapy response and immune microenvironmental remodeling. The study establishes a spatially informed framework for understanding macrophage-centered resistance mechanisms in gastric cancer.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: